Lawsuits against Juul echo opioid cases
New York and California have sued the e-cigarette company for deceptive marketing that contributed to a public health crisis.
Opioids
Timeline: Pharma navigates the first federal opioid trial
The case brought by two Ohio counties was set to be a bellwether for the remaining federal lawsuits.
Last-minute settlements delay Ohio opioid trial
Three drug distributors and a pharma company reached deals to avoid going to trial Monday.
Has CME put a dent in the opioid crisis? The jury’s still out
Despite 900 courses and 500,000 learners, the effort has missed the mark on some core goals.
Creative agency Terri & Sandy help fight opioid epidemic with pro-bono work
The shop has created a drive with the Partnership for Drug-Free Kids.
Purdue Pharma reaches first opioid-related lawsuit settlement
Purdue is settling a lawsuit brought by Oklahoma for $270 million. It is facing more than 1,600 lawsuits nationwide.
Reports: Purdue weighs Chapter 11
The drugmaker is facing thousands of lawsuits saying the company contributed to the opioid crisis.
Study: Marketing opioids to doctors tied to increased overdose deaths
Researchers looked at the connections between the amount of marketing to doctors and opioid overdose deaths in a study published in JAMA.
Five things for pharma marketers to know: Wednesday, September 12, 2018
FDA threatens to ban flavored vapes; Cigna launches $250 million venture fund; Takeda shutters Chicago operations.
Purdue’s sales force targeted high prescribers with a ‘false narrative,’ unsealed lawsuit says
Directing its reps to call on GPs with little to no opioid experience, Purdue introduced aggressive promotional tactics into the prescription opioid marketing playbook.
